Influence of genetic discrimination perceptions and knowledge on cancer genetics referral practice among clinicians

Genetics in Medicine

Volumn 10, Issue 9, 2008, Pages 691-698

  Lowstuter, Katrina J ^a   Sand, Sharon ^a   Blazer, Kathleen R ^a   MacDonald, Deborah J ^a   Banks, Kimberly C ^a,f   Lee, Carol A ^b   Schwerin, Barbara U ^c   Juarez, Margaret ^d   Uman, Gwen C ^e   Weitzel, Jeffrey N ^a  

^a Department of Clinical Cancer Genetics ^*  (United States)

^b California Medical Association   (United States)

^c Loyola Law School Los Angeles   (United States)

^d California Latino Medical Association   (United States)

^e Vital Research LLC   (United States)

^f ST JOSEPH HOSPITAL   (United States)

Author keywords

Cancer genetics; Education; Genetic discrimination; Genetic testing; Health insurance; Insurance discrimination; Nurse practitioner; Physician

Indexed keywords

ADULT; ARTICLE; CANCER GENETICS; FEMALE; GENETIC ANALYSIS; HEALTH INSURANCE; HUMAN; KNOWLEDGE; LAW; LOGISTIC REGRESSION ANALYSIS; MALE; NORMAL HUMAN; NURSE PRACTITIONER; PATIENT REFERRAL; PERCEPTION; PHYSICIAN; SOCIAL DISCRIMINATION; TREATMENT REFUSAL; CANCER DIAGNOSIS; CLINICAL PRACTICE; GENETIC COUNSELING; GENETIC PRIVACY; GENETIC SCREENING; HEALTH PERSONNEL ATTITUDE; MIDDLE AGED; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; RISK ASSESSMENT; STATISTICAL MODEL; STATISTICS; UNITED STATES;

ADULT; ATTITUDE OF HEALTH PERSONNEL; CALIFORNIA; EARLY DETECTION OF CANCER; FEMALE; GENETIC COUNSELING; GENETIC PRIVACY; GENETIC SCREENING; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NURSE PRACTITIONERS; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS; QUESTIONNAIRES; REFERRAL AND CONSULTATION; RISK ASSESSMENT;

EID: 58249083554     PISSN: 10983600     EISSN: None     Source Type: Journal    
DOI: 10.1097/GIM.0b013e3181837246     Document Type: Article

References (48)

1. Daly MB, Axilbund JE, Bryant E, et al. Genetic/familial high-risk assessment: breast and ovarian. J Natl Compr Canc Netw 2006;4:156-176.
2. American Society of Clinical Oncology. American society of clinical oncology policy statement update: genetic testing for cancer susceptibility. J Clin Oncol 2003;21: 2397-2406.
3. Billings PR, Kohn MA, de Cuevas M, Beckwith J, Alper JS, Natowicz MR. Discrimination as a consequence of genetic testing. Am J Hum Genet 1992;50:476-482.
4. Hall MA, McEwen JE, Barton JC, et al. Concerns in a primary care population about genetic discrimination by insurers. Genet Med 2005;7:311-316.
5. Hall MA, Rich SS. Patients' fear of genetic discrimination by health insurers: the impact of legal protections. Genet Med 2000;2:214-221.
6. Rose AL, Peters N, Shea JA, Armstrong K. Attitudes and misconceptions about predictive genetic testing for cancer risk. Community Genet 2005;8:145-151.
7. Lapham EV, Kozma C, Weiss JO. Genetic discrimination: perspectives of consumers. Science 1996;274:621-624.
8. Kass NE, Hull SC, Natowicz MR, et al. Medical privacy and the disclosure of personal medical information: the beliefs and experiences of those with genetic and other clinical conditions. Am J Med Genet A 2004;128A:261-270.
9. Hadley DW, Jenkins J, Dimond E, et al. Genetic counseling and testing in families with hereditary nonpolyposis colorectal cancer. Arch Intern Med 2003;163:573-582.
10. Health Insurance Portability and Accountability Act of 1996. Public law 104-191. US Statut Large 1996;110:1936-2103.
11. Office for Civil Rights, HHS. Standards for privacy of individually identifiable health information. Final rule. Fed Regist 2002;67:53181-53273.
12. Legislatures NCoS. Genetics and Health Insurance State Anti-Discrimination Laws. Genetic Technologies Project. NCSL Genetics Tables 2007 [cited February 13, 2008]. Available at: http://www.ncsl.org/programs/ health/genetics/ndishlth.htm.
13. Compliance Manual. Commission TUSEEO. 1995:902-945.
14. Burlington Northern settles suit over genetic testing. New York Times April 19, 2001.
15. Reilly PR. Genetic risk assessment and insurance. Genet Test 1998;2:1-41.
16. Volpe LC. Genetic testing and health insurance practices: an industry perspective. Genet Test 1998;2:9-12.
17. PollitzK, Peshkin BN, BangitE, LuciaK. Genetic discriminationinhealth insurance: current legal protections and industry practices. Inquiry 2007;44:350-368.
18. Wingrove K, Norris J, Barton P, Hagerman R. Experiences and attitudes concerning genetic testing and insurance in a Colorado population: a survey of families diagnosed with fragile X syndrome. Am J Med Genet 1996;64:378-381.
19. Nedelcu R, Blazer KR, Schwerin BU, et al. Genetic discrimination: the clinician perspective. Clin Genet 2004;66:311-317.
20. Freedman AN, Wideroff L, Olson L, et al. US physicians' attitudes toward genetic testing for cancer susceptibility. Am J Med Genet A 2003;120A:63-71. (Pubitemid 37063834)
21. Ulrich CM, Kristal AR, White E, Hunt JR, Durfy SJ, Potter JD. Genetic testing for cancer risk: a population survey on attitudes and intention. Community Genet 1998; 1:213-222.
22. Matloff ET, Shappell H,BrierleyK,Bernhardt BA, Mckinnon W,Peshkin BN. What would you do? Specialists' perspectives on cancer genetic testing, prophylactic surgery, and insurance discrimination. J Clin Oncol 2000;18:2484-2492.
23. Weitzel JN. Genetic cancer risk assessment: putting it all together. Cancer 1999; 86(11 Suppl):2483-2492.
24. Daly MB, Axibund JE, Bryant E, et al. NCCN practice guidelines in oncology: genetic/familial high-risk assessment: breast and ovarian. 2007. Available at: http:// www.nccn.org/professionals/physician-gls/PDF/genetics- screening.pdf. Accessed March 22, 2007.
25. Dillman DA, Christensen JA, Carpenter EH, Brooks RM. Increasing mail questionnaire response: a four state comparison. Am Sociol Rev 1974;39:746-755.
26. Jarvinen HJ, Aarnio M, Mustonen H, et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastro-enterology 2000;118:829-834.
27. Rebbeck TR, Friebel T, Lynch HT, et al. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE study group. J Clin Oncol 2004;22:1055-1062. (Pubitemid 41095038)
28. Rebbeck TR, Lynch HT, Neuhausen SL, et al. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med 2002;346:1616-1622.
29. Warner E, Plewes DB, Hill KA, et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 2004;292:1317-1325. (Pubitemid 39223222)
30. Lee SC, Bernhardt BA, Helzlsouer KJ. Utilization of BRCA1/2 genetic testing in the clinical setting: report from a single institution. Cancer 2002;94:1876-1885.
31. Peterson EA, Milliron KJ, Lewis KE, Goold SD, Merajver SD. Health insurance and discrimination concerns and BRCA1/2 testing in a clinic population. Cancer Epidemiol Biomarkers Prev 2002;11:79-87.
32. Thompson HS, Valdimarsdottir HB, Duteau-Buck C, et al. Psychosocial predictors of BRCA counseling and testing decisions among urban African-American women. Cancer Epidemiol Biomarkers Prev 2002;11:1579-1585.
33. Blazer KR, Grant M, Sand SR, MacDonald DJ, Uman GC, Weitzel JN. Effects of a cancer genetics education programme on clinicians knowledge and practice. J Med Genet 2004;41:518-522.
34. Huizenga CR, Lowstuter K, Banks KC, et al. Genetic discrimination: a survey of cancer genetics professionals' knowledge, attitudes, and practices. In: 57th Annual American Society of Hum Genet Meeting, San Diego, CA, 2007.
35. Acton RT, Burst NM, Casebeer L, et al. Knowledge, attitudes, and behaviors of Alabama's primary care physicians regarding cancer genetics. Acad Med 2000;75: 850-852.
36. Maheux B, Legault C, Lambert J. Increasing response rates in physicians' mail surveys: an experimental study. Am J Public Health 1989;79:638-639.
37. Sobal J, Valente CM, Muncie HL Jr, Levine DM, Deforge BR. Physicians' beliefs about the importance of 25 health promoting behaviors. Am J Public Health 1985; 75:1427-1428.
38. Cartwright A. Professionals as responders: variations in and effects of response rates to questionnaires, 1961-1977. BMJ 1978;2:1419-1421.
39. Emmons KM, Stoddard AM, Fletcher R, et al. Cancer prevention among working class, multiethnic adults: results of the healthy directions-health centers study. Am J Public Health 2005;95:1200-1205.
40. Ricker C, Lagos V, Feldman N, et al. If we build it. Will they come? establishing a cancer genetics services clinic for an underserved predominantly Latina cohort. J Genet Couns 2006;15:505-514.
41. Ricker CN, Hiyama S, Fuentes S, et al. Beliefs and interest in cancer risk in an underserved Latino cohort. Prev Med 2007;44:241-245.
42. Jaeger AS, Mulholland WF II. Impact of genetic privacy legislation on insurer behavior. Genet Test 2000;4:31-42.
43. Wideroff L, Freedman AN, Olson L, et al. Physician use of genetic testing for cancer susceptibility: results of a national survey. Cancer Epidemiol Biomarkers Prev 2003; 12:295-303. (Pubitemid 36427989)
44. Wideroff L, Vadaparampil ST, Greene MH, Taplin S, Olson L, Freedman AN. Hereditary breast/ovarian and colorectal cancer genetics knowledge in a national sample of US physicians. J Med Genet 2005;42:749-755.
45. Maradiegue A, Edwards QT, Seibert D, Macri C, Sitzer L. Knowledge, perceptions, and attitudes of advanced practice nursing students regarding medical genetics. J Am Acad Nurse Pract 2005;17:472-479.
46. Harvey EK, Fogel CE, Peyrot M, Christensen KD, Terry SF, McInerney JD. Providers' knowledge of genetics: a survey of 5915 individuals and families with genetic conditions. Genet Med 2007;9:259-267.
47. Beckman M. Genetic nondiscrimination legislation could improve cancer preven-tion if it passes. J Natl Cancer Inst 2007;99:993-995.
48. Establishing federal protections against genetic discrimination [position paper]. Philadelphia: American College of Physicians 2008. (Available from American College of Physicians, 190 N. Independence Mall West, Philadelphia, PA 19106).